Cardiol Therapeutics Inc 20-F for FY2023
Cardiol Therapeutics Inc. (CRDL)
20-F
2024-04-01
For: 2023-12-31
View Original
Added on
April 09, 2026
About this 20-F
Cardiol Therapeutics Inc filed this 20-F on April 1, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- 28.13M CAD
- compared with a net loss of 30.93M CAD a year earlier
- Diluted EPS
- -0.44 CAD
- compared with -0.49 CAD a year earlier